CLINICAL_TRIALS
trial_result
· 2018-04-09
Clinical Trial Update: Human Rabies Immunoglobulin (HRIG)- Dosage Determination and Interference With the Active Immune Response [NA]
Summary
A completed clinical study evaluating the dosing of human rabies immunoglobulin (HRIG) and its effect on the development of an active immune response to rabies …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Queen Saovabha Memorial Institute | Conditions: Rabies | NA | Status: COMPLETED